Bortezomib PharmaS 3,5 mg prašak za otopinu za injekciju
| Name | Bortezomib PharmaS 3,5 mg prašak za otopinu za injekciju |
|---|---|
| Marketing Authorisation Number | HR-H-002821692 |
| Active Substance | bortezomib |
| Composition | jedna bočica sadrži 3,5 mg bortezomiba (u obliku estera boronatne kiseline i manitola) |
| Pharmaceutical Form | prašak za otopinu za injekciju |
| Manufacturer | Synthon Hispania S.L., Barcelona, Španjolska
Synthon s.r.o., Blansko, Češka |
| Marketing Authorisation Holder | PharmaS d.o.o., Radnička cesta 47, Zagreb, Hrvatska |
| Marketing Authorisation Date | 15.05.2020 |
| MA Period of Validity | unlimited |
| Classification Number | UP/I-530-09/19-02/177 |
| Registration Number | 381-12-01/70-20-05 |
| Prescription | Medicinal product subject to medical prescription |
| Type of prescription | Medicinal product subject to restricted medical prescription |
| Distribution | Supply through pharmacies (community) |
| Advertising to general public | not allowed |
| ATC Code | L01XG01 |
| Marketing status | Marketed |
| Shortage status | No shortage |
| SmPC | download |
| PL | download |
| Public Assessment Report | download |
